Sulfoxanthicillin from the deep-sea derived Penicillium sp. SCSIO sof101: an antimicrobial compound against Gram-positive and -negative pathogens

Natural products along with their analogs have been intensively explored for their antimicrobial potential against ‘ESKAPE’ pathogens. Herein, we report a new natural product with strong antibacterial activity, sulfoxanthocillin ( 1 ), along with its decomposed product peniformamide ( 2 ), and the k...

Full description

Saved in:
Bibliographic Details
Published inJournal of antibiotics Vol. 76; no. 3; pp. 113 - 120
Main Authors Yang, Jiafan, Song, Yongxiang, Zhou, Zhenbin, Huang, Yun, Wang, Songtao, Yuan, Jie, Wong, Nai-Kei, Yan, Yan, Ju, Jianhua
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.03.2023
Springer Nature
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Natural products along with their analogs have been intensively explored for their antimicrobial potential against ‘ESKAPE’ pathogens. Herein, we report a new natural product with strong antibacterial activity, sulfoxanthocillin ( 1 ), along with its decomposed product peniformamide ( 2 ), and the known compound xanthocillin X ( 3 ) from the deep-sea derived Penicillium sp. SCSIO sof101. The structures of compounds 1 and 2 were determined by extensive spectroscopic analysis. Compound 1 showed significant activity against series pathogens with MIC values ranging 0.06–8.0 μg mL −1 . As an artificial unnatural product during the isolation process, compound 2 had lower antimicrobial activity than that of compound 1 , which could be attributed to a change in structural modification from an isonitrile group in compound 1 to a formamide group in compound 2 . In terms of cytotoxicity, 1 showed relatively low cytotoxicity against human tumor cell lines compared with xanthocillin X ( 3 ), suggesting that the sulfate group present in 1 should be a determinant of cytotoxic activities. Overall, sulfoxanthocillin ( 1 ) merits further attention as a potential lead compound for anti-infective interventions against Gram-negative and Gram-positive bacterial pathogens.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0021-8820
1881-1469
1881-1469
DOI:10.1038/s41429-022-00593-9